Corticosteroids alter the differentiated phenotype of articular chondrocytes
Authors:
- Rory J. TodhunterRTRory J. Todhunter
- Nancy Burton‐WursterNBNancy Burton‐Wurster
- Margaret Vernier‐SingerMVMargaret Vernier‐Singer
- James N. MacleodJMJames N. Macleod
- 1 July 2001
- journal article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 19 (4) , 688-695
Abstract
Experimental evidence suggests that recommended dosages of some corticosteroids used clinically as antiinflammatory agents for treating arthropathies damage articular cartilage, but low dosages may be chondroprotective. The purpose of this study was to evaluate how different concentrations of methylprednisolone affect chondrocyte function and viability. Articular cartilage and chondrocytes were obtained from young adult horses, 1.5–3.5 years of age. Corticosteroid‐induced changes in collagen expression were studied at the transcriptional level by Northern blot analyses and at the translational level by measuring [3H]‐proline incorporation into [3H]‐hydroxyproline. Fibronectin mRNA splicing patterns were evaluated with ribonuclease protection assays. Cytotoxicity was studied using erythrosin B dye exclusion. Steady‐state levels of type II procollagen mRNA decreased without concurrent changes in type I procollagen expression as the medium methylprednisolone concentrations were increased from 1 × 101to 1 × 108pg/ml, dropping below 10% of control values by 1 × 105pg/ml. Cytotoxicity occurred as methylprednisolone levels were increased further from 1 × 108to 1 × 109pg/ml. Changes in total collagen (protein) synthesis were less pronounced, but also demonstrated significant suppression between 1 × 104and 1 × 108pg/ml. Corticosteroid‐induced changes in fibronectin isoform levels were evaluated in articular cartilage samples without in vitro culture. The cartilage‐specific (V + C)−isoform was suppressed in both normal and inflamed joints by a single intraarticular injection (0.1 mg/kg) of methylprednisolone. Combined, these data indicate that methylprednisolone suppresses matrix protein markers of chondrocytic differentiation. Decreased and altered chondrocyte expression of matrix proteins likely contributes to the pathogenesis of corticosteroid‐induced cartilage degeneration. © 2001 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.Keywords
This publication has 42 references indexed in Scilit:
- Expression of the (V+C)− fibronectin isoform is tightly linked to the presence of a cartilaginous matrixMatrix Biology, 1998
- Expression of a stable articular cartilage phenotype without evidence of hypertrophy by adult human articular chondrocytes in vitroJournal of Orthopaedic Research, 1998
- Osteoarthritis chondrocytes die by apoptosis: A possible pathway for osteoarthritis pathologyArthritis & Rheumatism, 1998
- Glucocorticoid TherapyVeterinary Clinics of North America: Small Animal Practice, 1997
- Cartilage fibronectin isoforms: In search of functions for a special populations of matrix glycoproteinsMatrix Biology, 1997
- Reexpression of Cartilage-Specific Genes by Dedifferentiated Human Articular Chondrocytes Cultured in Alginate BeadsExperimental Cell Research, 1994
- Changes in the coxofemoral articular cartilage in Wistar rats after systemic administration of corticoidsAnnals of Anatomy - Anatomischer Anzeiger, 1993
- Fibronectin and proteoglycan synthesis in long term cultures of cartilage explants in Ham's F12 supplemented with insulin and calcium: Effects of the addition of TGF-βArchives of Biochemistry and Biophysics, 1990
- Synovial fluid and plasma kinetics of methylprednisolone and methylprednisolone acetate in horses following intra‐articular administration of methylprednisolone acetateEquine Veterinary Journal, 1986
- Reduced deposition of collagen in the degenerated articular cartilage of dogs with degenerative joint diseaseBiochimica et Biophysica Acta (BBA) - General Subjects, 1982